Please login to the form below

Not currently logged in

Novartis says its biosimilar sales should reach $1bn this year

Novartis Gehry Building, Basel, SwitzerlandFour-drug portfolio grew by 40% to $262m in the quarter

Merck gets early OK for Keytruda in first-line lung cancer

Merck and Co - US headquartersFDA fast-tracks approval of PD-1/PD-L1 inhibitor for treatment of NSCLC

GSK's blockbuster hopeful Shingrix filed in US

GSK - logo on buildingClinical data showed shingles vaccine had 90% efficacy in elderly patients

Pharma 'could do better' on social media engagement

Industry is comfortable with the tech but has work to do on its approach

Astronauts to trial healthcare wearables in space

Canadian Space Agency plans to test a 'smart shirt' in an upcoming mission

After delay, Merck gets US approval for serious infection drug

Merck and Co - US headquartersZinplava anticipated to accrue $300m in sales by 2020

Keytruda, Opdivo narrow Tecentriq's lead in bladder cancer

Bristol-Myers Squibb (BMS) buildingBMS’ drug is currently under FDA and EMA review in advanced urothelial carcinoma

Rigel shaken after fostamatinib misses phase III trial target

RigelFirm will still pursue early 2017 FDA approval for the autoimmune disease therapy

Overriding the main frame

Leveraging behavioural biases to our advantage

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company
Serviceplan Health & Life

We are your creative global lead agency, your Pan-European hub and your worldwide network....

Latest intelligence

Access to orphan drugs for rare cancers in EU28
Revisiting Instagram for pharma
In pharma, Instagram usage is increasing because it offers so many benefits to engage with patients and HCPs...
The one multichannel question you must ask
There is a question every marketer should ask when designing a multichannel communications strategy...